January 31, 2023 Last patient included in AlzeCure’s Phase II clinical trial in peripheral neuropathic pain with the non-opioid ACD440
January 11, 2023 AlzeCure selects CD and enters next development phase with Alzstatin ACD680 against Alzheimer’s
